← Insider buys
ITCI

Intra-Cellular Therapies, Inc.

EVP and Chief Commercial Officer Mark Neumann sold $191K of Intra-Cellular Therapies, Inc.

Sold$190,648
$47.12Price
4,046Shares
−7%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Fri, Feb 24. Filed Mon, Feb 27, 3:03 PM ET, during the session. Not investment advice.